Technical Analysis for CNAT - Conatus Pharmaceuticals Inc.
|Grade||Last Price||% Change||Price Change|
CNAT closed down 1.16 percent on Friday, February 16, 2018, on 74 percent of normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
|Weak or Absent||Down||Up||Up|
|See historical CNAT trend table...|
|Date||Alert Name||Type||% Chg|
|Feb 16||200 DMA Resistance||Bearish||0.00%|
|Feb 16||Shooting Star Candlestick||Bearish||0.00%|
|Feb 16||Wide Bands||Range Expansion||0.00%|
|Feb 15||Narrow Range Bar||Range Contraction||-1.16%|
|Feb 15||NR7||Range Contraction||-1.16%|
|Feb 15||NR7-2||Range Contraction||-1.16%|
|Feb 15||Wide Bands||Range Expansion||-1.16%|
|Feb 14||Non-ADX 1,2,3,4 Bullish||Bullish Swing Setup||0.99%|
|Feb 14||Narrow Range Bar||Range Contraction||0.99%|
|Feb 14||NR7||Range Contraction||0.99%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of medicines to treat liver diseases in the United States. Its products include Emricasan, an orally active caspase protease inhibitor for the treatment of acute-on-chronic liver failure and chronic liver failure, as well as for the patients who have developed liver fibrosis post-orthotopic liver transplant due to Hepatitis C virus infection. The company was founded in 2005 and is headquartered in San Diego, California.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more CNAT news...
|52 Week High||9.4|
|52 Week Low||3.88|
|200-Day Moving Average||5.2|
|50-Day Moving Average||4.8384|
|20-Day Moving Average||5.206|
|10-Day Moving Average||5.033|
|Average True Range||0.3437|
|Chandelier Exit (Long, 3 ATRs )||4.9189|
|Chandelier Exit (Short, 3 ATRs )||5.6311|
|Upper Bollinger Band||5.7191|
|Lower Bollinger Band||4.6929|
|Percent B (%b)||0.42|
|MACD Signal Line||0.0884|
|Market Cap||153.62 Million|
|Num Shares||30 Million|
|Price-to-Earnings (P/E) Ratio||-5.22|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||5.51|
|Resistance 3 (R3)||5.54||5.45||5.45|
|Resistance 2 (R2)||5.45||5.35||5.43||5.42|
|Resistance 1 (R1)||5.28||5.29||5.24||5.25||5.40|
|Support 1 (S1)||5.02||5.09||4.98||4.99||4.84|
|Support 2 (S2)||4.93||5.03||4.91||4.82|
|Support 3 (S3)||4.76||4.93||4.80|
|Support 4 (S4)||4.73|